MEG3 Activated by Vitamin D Inhibits Colorectal Cancer Cells Proliferation and Migration via Regulating Clusterin

Aggarwal, 2016, Cross talk between the calcium-sensing receptor and the vitamin D system in prevention of cancer, Front. Physiol., 7, 451, 10.3389/fphys.2016.00451 Arnold, 2017, Global patterns and trends in colorectal cancer incidence and mortality, Gut, 66, 683, 10.1136/gutjnl-2015-310912 Bando, 1999, Loss of heterozygosity of 14q32 in colorectal carcinoma, Cancer Genet. Cytogenet., 111, 161, 10.1016/S0165-4608(98)00242-8 Cai, 2017, Prognostic biomarker identification through integrating the gene signatures of hepatocellular carcinoma properties, EBioMedicine, 19, 18, 10.1016/j.ebiom.2017.04.014 Chen, 2003, Clusterin as a biomarker in murine and human intestinal neoplasia, Proc. Natl. Acad. Sci. U. S. A., 100, 9530, 10.1073/pnas.1233633100 Deng, 2013, The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival, PLoS One, e76450, 8 Duffy, 2017, Vitamin D analogues: potential use in cancer treatment, Crit. Rev. Oncol. Hematol., 112, 190, 10.1016/j.critrevonc.2017.02.015 Elimrani, 2017, Vitamin D reduces colitis- and inflammation-associated colorectal Cancer in mice independent of NOD2, Nutr. Cancer, 69, 276, 10.1080/01635581.2017.1263346 Guinney, 2015, The consensus molecular subtypes of colorectal cancer, Nat. Med., 21, 1350, 10.1038/nm.3967 Jiang, 2014, LncRNA profiling reveals new mechanism for VDR protection against skin cancer formation, J. Steroid Biochem. Mol. Biol., 144, 87 Jiang, 2014, LncRNA: a new player in 1alpha, 25(OH)(2) vitamin D(3)/VDR protection against skin cancer formation, Exp. Dermatol., 23, 147, 10.1111/exd.12341 Kong, 2016, Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer, Oncotarget, 7, 50428, 10.18632/oncotarget.10416 Lee, 2016, eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells, Oncotarget, 7, 18541, 10.18632/oncotarget.8105 Li, 2014, Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis, J. Clin. Endocrinol. Metab., 99, 2327, 10.1210/jc.2013-4320 Li, 2016, Clusterin induced by N,N′-Dinitrosopiperazine is involved in nasopharyngeal carcinoma metastasis, Oncotarget, 7, 5548, 10.18632/oncotarget.6750 Li, 2017, MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis, Oncol. Rep., 38, 1383, 10.3892/or.2017.5828 Li, 2018, LncRNA MEG3 inhibits cell proliferation and metastasis in chronic myeloid leukemia via targeting MiR-184, Oncol. Res., 26, 297, 10.3727/096504017X14980882803151 Lin, 2015, Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: results from the surveillance epidemiology and end results (SEER) database, Oncotarget, 6, 33935, 10.18632/oncotarget.5223 Lu, 2013, Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression, BMC Cancer, 13, 461, 10.1186/1471-2407-13-461 Luo, 2017, Long non-coding RNAs: a rising biotarget in colorectal cancer, Oncotarget, 8, 22187, 10.18632/oncotarget.14728 Ma, 2016, Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/beta-catenin signalling pathway via suppression of activator protein 2alpha, Gut, 65, 1494, 10.1136/gutjnl-2014-308392 Marchese, 2017, The multidimensional mechanisms of long noncoding RNA function, Genome Biol., 18, 206, 10.1186/s13059-017-1348-2 Menigatti, 2013, Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions, Oncogene, 2 Modali, 2015, Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors, Mol. Endocrinol., 29, 224, 10.1210/me.2014-1304 Mondal, 2015, MEG3 long noncoding RNA regulates the TGF-beta pathway genes through formation of RNA-DNA triplex structures, Nat. Commun., 6, 7743, 10.1038/ncomms8743 Morales-oyarvide, 2016, Vitamin D and physical activity in patients with colorectal Cancer: epidemiological evidence and therapeutic implications, Cancer J., 22, 223, 10.1097/PPO.0000000000000197 Ohtsuka, 2016, H19 noncoding RNA, an independent prognostic factor, regulates essential Rb-E2F and CDK8-beta-catenin signaling in colorectal Cancer, EBioMedicine, 13, 113, 10.1016/j.ebiom.2016.10.026 Pan, 2015, Endoplasmic reticulum ribosome-binding protein 1, RRBP1, promotes progression of colorectal cancer and predicts an unfavourable prognosis, Br. J. Cancer, 113, 763, 10.1038/bjc.2015.260 Ponting, 2009, Evolution and functions of long noncoding RNAs, Cell, 136, 629, 10.1016/j.cell.2009.02.006 Radziwon-Balicka, 2014, Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway, Carcinogenesis, 35, 324, 10.1093/carcin/bgt332 Ramagopalan, 2010, A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution, Genome Res., 20, 1352, 10.1101/gr.107920.110 Su, 2016, Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163, Tumour Biol., 37, 3925, 10.1007/s13277-015-4151-2 Torre, 2015, Global cancer statistics, 2012, CA Cancer J. Clin., 65, 87, 10.3322/caac.21262 Walsh, 2003, Colorectal cancer screening: scientific review, JAMA, 289, 1288, 10.1001/jama.289.10.1288 Wang, 2012, Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression, J. Chemother., 24, 348, 10.1179/1973947812Y.0000000049 Wang, 2015, Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma, Oncotarget, 6, 2903, 10.18632/oncotarget.3093 Wu, 2015, LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression, Oncotarget, 6, 32890, 10.18632/oncotarget.5335 Yan, 2009, Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis, EMBO J., 28, 2719, 10.1038/emboj.2009.214 Yin, 2015, Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer, Tumour Biol., 36, 4851, 10.1007/s13277-015-3139-2 Yu, 2015, Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer, Gut, 64, 636, 10.1136/gutjnl-2013-306620 Yuan, 2017, The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1, Nat. Cell Biol., 19, 820, 10.1038/ncb3538 Zhang, 2003, A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells, J. Clin. Endocrinol. Metab., 88, 5119, 10.1210/jc.2003-030222 Zhang, 2017, LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer, Biomed Pharmacother, 91, 312, 10.1016/j.biopha.2017.04.085 Zhao, 2006, Cyclic AMP stimulates MEG3 gene expression in cells through a cAMP-response element (CRE) in the MEG3 proximal promoter region, Int. J. Biochem. Cell Biol., 38, 1808, 10.1016/j.biocel.2006.05.004 Zhou, 2012, MEG3 noncoding RNA: a tumor suppressor, J. Mol. Endocrinol., 48, R45, 10.1530/JME-12-0008 Zhu, 2013, Function of lncRNAs and approaches to lncRNA-protein interactions, Sci. China Life Sci., 56, 876, 10.1007/s11427-013-4553-6 Zwain, 2001, cAMP-induced apoptosis in granulosa cells is associated with up-regulation of P53 and bax and down-regulation of clusterin, Endocr. Res., 27, 233, 10.1081/ERC-100107184